{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:49:31Z","timestamp":1793116171292,"version":"4.5.0"},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9371","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T10:57:37Z","timestamp":1535540257000},"source":"Crossref","is-referenced-by-count":3,"title":["Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing"],"prefix":"10.3892","author":[{"given":"Bo\u2011Lun","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Clinical Medical College of Weifang Medical University, Weifang, Shandong 261042, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling\u2011Xiang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao\u2011Hui","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De\u2011Xi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang\u2011Hao","family":"Diao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia\u2011Yi","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao\u2011Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang\u2011Lin","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui\u2011Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian\u2011Zhong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng\u2011Hui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing\u2011Yu","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Precision Medicine, 3D Medicines, Inc., Shanghai 201114, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia\u2011Jia","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Precision Medicine, 3D Medicines, Inc., Shanghai 201114, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao\u2011Geng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, 302 Military Hospital of China, Beijing 100039, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"key20200714084328_b1-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20200714084328_b2-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"key20200714084328_b3-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"key20200714084328_b4-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"key20200714084328_b5-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res"},{"key":"key20200714084328_b6-ol-0-0-9371","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1470-7330-14-14","article-title":"Imaging of malignancies of the biliary tract-an update","volume":"14","author":"Hennedige","year":"2014","journal-title":"Cancer Imaging"},{"key":"key20200714084328_b7-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11864-016-0432-2","article-title":"Genomic profiling of biliary tract cancers and implications for clinical practice","volume":"17","author":"Jain","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"key20200714084328_b8-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"797","DOI":"10.21037\/jgo.2016.09.01","article-title":"Molecular profiling of biliary tract cancer: A target rich disease","volume":"7","author":"Jain","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"key20200714084328_b9-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat Genet"},{"key":"key20200714084328_b10-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res"},{"key":"key20200714084328_b11-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat Genet"},{"key":"key20200714084328_b12-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1038\/ncomms12992","article-title":"Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat Commun"},{"key":"key20200714084328_b13-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/nsr\/nwu038","article-title":"The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma","volume":"1","author":"Yang","year":"2014","journal-title":"Natl Sci Rev"},{"key":"key20200714084328_b14-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/liv.12469","article-title":"Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma","volume":"35","author":"Tang","year":"2015","journal-title":"Liver Int"},{"key":"key20200714084328_b15-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1099\/vir.0.19650-0","article-title":"Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin","volume":"85","author":"Pan","year":"2004","journal-title":"J Gen Virol"},{"key":"key20200714084328_b16-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"e41931","DOI":"10.1371\/journal.pone.0041931","article-title":"Hepatitis B virus X protein upregulates mTOR signaling through IKK\u03b2 to increase cell proliferation and VEGF production in hepatocellular carcinoma","volume":"7","author":"Yen","year":"2012","journal-title":"PLoS One"},{"key":"key20200714084328_b17-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1002\/hep.25899","article-title":"Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"key20200714084328_b18-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2010.09.018","article-title":"Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt\/\u03b2-catenin signaling","volume":"300","author":"Hsieh","year":"2011","journal-title":"Cancer Lett"},{"key":"key20200714084328_b19-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2011.05.033","article-title":"Hepatitis B virus X protein stimulates the Hedgehog-Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells","volume":"309","author":"Kim","year":"2011","journal-title":"Cancer Lett"},{"key":"key20200714084328_b20-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"key20200714084328_b21-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2010.08.019","article-title":"Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma","volume":"9","author":"Yang","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20200714084328_b22-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200714084328_b23-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ccell.2016.04.004","article-title":"Squamous cell cancers: A unified perspective on biology and genetics","volume":"29","author":"Dotto","year":"2016","journal-title":"Cancer Cell"},{"key":"key20200714084328_b24-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/hep.26425","article-title":"Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib","volume":"58","author":"Herraez","year":"2013","journal-title":"Hepatology"},{"key":"key20200714084328_b25-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","article-title":"Common molecular subtypes among asian hepatocellular carcinoma and cholangiocarcinoma","volume":"32","author":"Chaisaingmongkol","year":"2017","journal-title":"Cancer Cell"},{"key":"key20200714084328_b26-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrg3729","article-title":"Mechanisms underlying mutational signatures in human cancers","volume":"15","author":"Helleday","year":"2014","journal-title":"Nat Rev Genet"},{"key":"key20200714084328_b27-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ng.804","article-title":"High-resolution characterization of a hepatocellular carcinoma genome","volume":"43","author":"Totoki","year":"2011","journal-title":"Nat Genet"},{"key":"key20200714084328_b28-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke-associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"key":"key20200714084328_b29-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"e0123175","DOI":"10.1371\/journal.pone.0123175","article-title":"Identification of HBV-MLL4 integration and its molecular basis in chinese hepatocellular carcinoma","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"key20200714084328_b30-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jhep.2013.12.014","article-title":"The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma","volume":"60","author":"Li","year":"2014","journal-title":"J Hepatol"},{"key":"key20200714084328_b31-ol-0-0-9371","first-page":"95","article-title":"Dissecting the pleiotropic actions of HBx mutants against hypoxia in hepatocellular carcinoma","volume":"3","author":"Lee","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"key20200714084328_b32-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0168-8278(00)00090-8","article-title":"Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix","volume":"34","author":"Lara-Pezzi","year":"2001","journal-title":"J Hepatol"},{"key":"key20200714084328_b33-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200714084328_b34-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200714084328_b35-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200714084328_b36-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200714084328_b37-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"key20200714084328_b38-ol-0-0-9371","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:20:57Z","timestamp":1720549257000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9371","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]}}}